| Year |
Citation |
Score |
| 2024 |
Van Genechten T, De Laere M, Van den Bossche J, Stein B, De Rycke K, Deschepper C, Hazes K, Peeters R, Couttenye MM, Van De Walle K, Roelant E, Maes S, Vanden Bossche S, Dekeyzer S, Huizing M, ... ... Cools N, et al. Adjuvant Wilms' tumour 1-specific dendritic cell immunotherapy complementing conventional therapy for paediatric patients with high-grade glioma and diffuse intrinsic pontine glioma: protocol of a monocentric phase I/II clinical trial in Belgium. Bmj Open. 14: e077613. PMID 38503417 DOI: 10.1136/bmjopen-2023-077613 |
0.336 |
|
| 2023 |
Erdem R, De Coster I, Withanage K, Mercer LD, Marchant A, Taton M, Cools N, Lion E, Cassels F, Higgins D, Ivinson K, Locke E, Mahmood K, Wright PF, Gast C, et al. Safety, tolerability, and immunogenicity of inactivated poliovirus vaccine with or without E.coli double mutant heat-labile toxin (dmLT) adjuvant in healthy adults; a phase 1 randomized study. Vaccine. PMID 36746739 DOI: 10.1016/j.vaccine.2023.01.048 |
0.645 |
|
| 2022 |
Van Delen M, Janssens I, Dams A, Roosens L, Ogunjimi B, Berneman ZN, Derdelinckx J, Cools N. Tolerogenic Dendritic Cells Induce Apoptosis-Independent T Cell Hyporesponsiveness of SARS-CoV-2-Specific T Cells in an Antigen-Specific Manner. International Journal of Molecular Sciences. 23. PMID 36499533 DOI: 10.3390/ijms232315201 |
0.364 |
|
| 2021 |
Meena M, Van Delen M, De Laere M, Sterkens A, Costas Romero C, Berneman Z, Cools N. Transmigration across a Steady-State Blood-Brain Barrie Induces Activation of Circulating Dendritic Cells Partly Mediated by Actin Cytoskeletal Reorganization. Membranes. 11. PMID 34564517 DOI: 10.3390/membranes11090700 |
0.352 |
|
| 2020 |
Janssens I, Cools N. Regulating the regulators: Is introduction of an antigen-specific approach in regulatory T cells the next step to treat autoimmunity? Cellular Immunology. 358: 104236. PMID 33137651 DOI: 10.1016/j.cellimm.2020.104236 |
0.384 |
|
| 2020 |
Maes E, Cools N, Willems H, Baggerman G. FACS-Based Proteomics Enables Profiling of Proteins in Rare Cell Populations. International Journal of Molecular Sciences. 21. PMID 32911660 DOI: 10.3390/Ijms21186557 |
0.403 |
|
| 2019 |
Willekens B, Presas-Rodríguez S, Mansilla MJ, Derdelinckx J, Lee WP, Nijs G, De Laere M, Wens I, Cras P, Parizel P, Van Hecke W, Ribbens A, Billiet T, Adams G, Couttenye MM, ... ... Cools N, et al. Tolerogenic dendritic cell-based treatment for multiple sclerosis (MS): a harmonised study protocol for two phase I clinical trials comparing intradermal and intranodal cell administration. Bmj Open. 9: e030309. PMID 31501122 DOI: 10.1136/Bmjopen-2019-030309 |
0.397 |
|
| 2019 |
Derdelinckx J, Mansilla MJ, De Laere M, Lee WP, Navarro-Barriuso J, Wens I, Nkansah I, Daans J, De Reu H, Jolanta Keliris A, Van Audekerke J, Vanreusel V, Pieters Z, Van der Linden A, Verhoye M, ... ... Cools N, et al. Clinical and immunological control of experimental autoimmune encephalomyelitis by tolerogenic dendritic cells loaded with MOG-encoding mRNA. Journal of Neuroinflammation. 16: 167. PMID 31416452 DOI: 10.1186/S12974-019-1541-1 |
0.404 |
|
| 2019 |
Meena M, Cools N. On the road to new treatments for multiple sclerosis: targeting dendritic cell migration into the central nervous system. Neural Regeneration Research. 14: 2088-2090. PMID 31397344 DOI: 10.4103/1673-5374.262583 |
0.353 |
|
| 2019 |
Ten Brinke A, Martinez-Llordella M, Cools N, Hilkens CMU, van Ham SM, Sawitzki B, Geissler EK, Lombardi G, Trzonkowski P, Martinez-Caceres E. Ways Forward for Tolerance-Inducing Cellular Therapies- an AFACTT Perspective. Frontiers in Immunology. 10: 181. PMID 30853957 DOI: 10.3389/Fimmu.2019.00181 |
0.412 |
|
| 2019 |
Berneman Z, Anguille S, Willemen Y, de Velde AV, Germonpre P, Huizing M, Van Tendeloo V, Saevels K, Rutsaert L, Vermeulen K, Snoeckx A, de Beeck BO, Cools N, Nijs G, Stein B, et al. Vaccination of cancer patients with dendritic cells electroporated with mRNA encoding the wilms' tumor 1 protein (WT1): correlation of clinical effect and overall survival with T-cell response Cytotherapy. 21: S10. DOI: 10.1016/J.Jcyt.2019.03.565 |
0.743 |
|
| 2018 |
Willekens B, Cools N. Beyond the Magic Bullet: Current Progress of Therapeutic Vaccination in Multiple Sclerosis. Cns Drugs. PMID 29761344 DOI: 10.1007/S40263-018-0518-4 |
0.498 |
|
| 2018 |
De Laere M, Berneman ZN, Cools N. To the Brain and Back: Migratory Paths of Dendritic Cells in Multiple Sclerosis. Journal of Neuropathology and Experimental Neurology. PMID 29342287 DOI: 10.1093/Jnen/Nlx114 |
0.424 |
|
| 2018 |
Cools N, Presas-Rodríguez S, Mansilla MJ, Derdelinckx J, Lee WP, Nijs G, De Laere M, Wens I, Cras P, Parizel P, Van Hecke W, Ribbens A, Adams G, Couttenye M, Navarro-Barriuso J, et al. Towards a dendritic cell-based vaccine for the treatment of multiple sclerosis (MS): interim safety data of the first dose cohort of the MS-tolDC phase I clinical trial Frontiers in Neuroscience. 12. DOI: 10.3389/Conf.Fnins.2018.95.00060 |
0.375 |
|
| 2017 |
De Laere M, Derdelinckx J, Hassi M, Kerosalo M, Oravamäki H, Van den Bergh J, Berneman Z, Cools N. Shuttling Tolerogenic Dendritic Cells across the Blood-Brain Barrier In Vitro via the Introduction of De Novo C-C Chemokine Receptor 5 Expression Using Messenger RNA Electroporation. Frontiers in Immunology. 8: 1964. PMID 29403473 DOI: 10.3389/Fimmu.2017.01964 |
0.39 |
|
| 2017 |
Fuchs A, Gliwiński M, Grageda N, Spiering R, Abbas AK, Appel S, Bacchetta R, Battaglia M, Berglund D, Blazar B, Bluestone JA, Bornhäuser M, Ten Brinke A, Brusko TM, Cools N, et al. Minimum Information about T Regulatory Cells: A Step toward Reproducibility and Standardization. Frontiers in Immunology. 8: 1844. PMID 29379498 DOI: 10.3389/Fimmu.2017.01844 |
0.413 |
|
| 2017 |
Anguille S, Van de Velde AL, Smits EL, Van Tendeloo VF, Juliusson G, Cools N, Nijs G, Stein B, Lion E, Van Driessche A, Vandenbosch I, Verlinden A, Gadisseur AP, Schroyens WA, Muylle L, et al. Dendritic cell vaccination as post-remission treatment to prevent or delay relapse in acute myeloid leukemia. Blood. PMID 28830889 DOI: 10.1182/Blood-2017-04-780155 |
0.728 |
|
| 2017 |
Goldeck D, Theeten H, Hassouneh F, Oettinger L, Wistuba-Hamprecht K, Cools N, Tsitsilonis OE, Pawelec G. Frequencies of peripheral immune cells in older adults following seasonal influenza vaccination with an adjuvanted vaccine. Vaccine. PMID 28689651 DOI: 10.1016/J.Vaccine.2017.06.082 |
0.466 |
|
| 2017 |
De Laere M, Sousa C, Meena M, Buckinx R, Timmermans JP, Berneman Z, Cools N. Increased Transendothelial Transport of CCL3 Is Insufficient to Drive Immune Cell Transmigration through the Blood-Brain Barrier under Inflammatory Conditions In Vitro. Mediators of Inflammation. 2017: 6752756. PMID 28626344 DOI: 10.1155/2017/6752756 |
0.396 |
|
| 2017 |
Ogunjimi B, Van den Bergh J, Meysman P, Heynderickx S, Bergs K, Jansen H, Leuridan E, Vorsters A, Goossens H, Laukens K, Cools N, Van Tendeloo V, Hens N, Van Damme P, Smits E, et al. Multidisciplinary study of the secondary immune response in grandparents re-exposed to chickenpox. Scientific Reports. 7: 1077. PMID 28439065 DOI: 10.1038/S41598-017-01024-8 |
0.404 |
|
| 2017 |
Buckinx R, Alpaerts K, Pintelon I, Cools N, Van Nassauw L, Adriaensen D, Timmermans JP. In situ proximity of CX3CR1-positive mononuclear phagocytes and VIP-ergic nerve fibers suggests VIP-ergic immunomodulation in the mouse ileum. Cell and Tissue Research. PMID 28190088 DOI: 10.1007/S00441-017-2578-Z |
0.404 |
|
| 2017 |
Rombouts M, Cools N, Grootaert MO, de Bakker F, Van Brussel I, Wouters A, De Meyer GR, De Winter BY, Schrijvers DM. Long-Term Depletion of Conventional Dendritic Cells Cannot Be Maintained in an Atherosclerotic Zbtb46-DTR Mouse Model. Plos One. 12: e0169608. PMID 28060909 DOI: 10.1371/Journal.Pone.0169608 |
0.4 |
|
| 2016 |
Lee WP, Willekens B, Cras P, Goossens H, Martínez-Cáceres E, Berneman ZN, Cools N. Immunomodulatory Effects of 1,25-Dihydroxyvitamin D3 on Dendritic Cells Promote Induction of T Cell Hyporesponsiveness to Myelin-Derived Antigens. Journal of Immunology Research. 2016: 5392623. PMID 27703987 DOI: 10.1155/2016/5392623 |
0.479 |
|
| 2016 |
Lord P, Spiering R, Aguillon JC, Anderson AE, Appel S, Benitez-Ribas D, Ten Brinke A, Broere F, Cools N, Cuturi MC, Diboll J, Geissler EK, Giannoukakis N, Gregori S, van Ham SM, et al. Minimum information about tolerogenic antigen-presenting cells (MITAP): a first step towards reproducibility and standardisation of cellular therapies. Peerj. 4: e2300. PMID 27635311 DOI: 10.7717/Peerj.2300 |
0.384 |
|
| 2016 |
Nollet E, Hoymans VY, Rodrigus IR, De Bock D, Dom M, Vanassche B, Van Hoof VO, Cools N, Van Ackeren K, Wouters K, Vermeulen K, Vrints CJ, Van Craenenbroeck EM. Bone Marrow-Derived Progenitor Cells Are Functionally Impaired in Ischemic Heart Disease. Journal of Cardiovascular Translational Research. PMID 27456951 DOI: 10.1007/S12265-016-9707-Z |
0.322 |
|
| 2016 |
Van Damme P, Bouillette-Marussig M, Hens A, De Coster I, Depuydt C, Goubier A, Van Tendeloo V, Cools N, Goossens H, Hercend T, Timmerman B, Bissery MC. GTL001, A Therapeutic Vaccine for Women Infected with Human Papillomavirus 16 or 18 and Normal Cervical Cytology: Results of a Phase I Clinical Trial. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27252412 DOI: 10.1158/1078-0432.Ccr-16-0085 |
0.308 |
|
| 2016 |
Derdelinckx J, Berneman ZN, Cools N. GMP-Grade mRNA Electroporation of Dendritic Cells for Clinical Use. Methods in Molecular Biology (Clifton, N.J.). 1428: 139-50. PMID 27236797 DOI: 10.1007/978-1-4939-3625-0_9 |
0.433 |
|
| 2016 |
Mansilla MJ, Contreras-Cardone R, Navarro-Barriuso J, Cools N, Berneman Z, Ramo-Tello C, Martínez-Cáceres EM. Cryopreserved vitamin D3-tolerogenic dendritic cells pulsed with autoantigens as a potential therapy for multiple sclerosis patients. Journal of Neuroinflammation. 13: 113. PMID 27207486 DOI: 10.1186/S12974-016-0584-9 |
0.37 |
|
| 2016 |
Rombouts M, Ammi R, Van Brussel I, Roth L, De Winter BY, Vercauteren SR, Hendriks JM, Lauwers P, Van Schil PE, De Meyer GR, Fransen E, Cools N, Schrijvers DM. Linking CD11b (+) Dendritic Cells and Natural Killer T Cells to Plaque Inflammation in Atherosclerosis. Mediators of Inflammation. 2016: 6467375. PMID 27051078 DOI: 10.1155/2016/6467375 |
0.443 |
|
| 2016 |
Deckx N, Willekens B, Wens I, Eijnde BO, Goossens H, Van Damme P, Berneman ZN, Cools N. Altered molecular expression of TLR-signaling pathways affects the steady-state release of IL-12p70 and IFN-α in patients with relapsing-remitting multiple sclerosis. Innate Immunity. PMID 27036414 DOI: 10.1177/1753425916642615 |
0.393 |
|
| 2016 |
Theeten H, Mathei C, Peeters K, Ogunjimi B, Goossens H, Ieven M, Van Damme P, Cools N. Cellular Interferon Gamma and Granzyme B Responses to Cytomegalovirus-pp65 and Influenza N1 Are Positively Associated in Elderly. Viral Immunology. PMID 27002465 DOI: 10.1089/Vim.2015.0071 |
0.403 |
|
| 2016 |
Deckx N, Wens I, Nuyts AH, Hens N, De Winter BY, Koppen G, Goossens H, Van Damme P, Berneman ZN, Eijnde BO, Cools N. 12 Weeks of Combined Endurance and Resistance Training Reduces Innate Markers of Inflammation in a Randomized Controlled Clinical Trial in Patients with Multiple Sclerosis. Mediators of Inflammation. 2016: 6789276. PMID 26903712 DOI: 10.1155/2016/6789276 |
0.349 |
|
| 2016 |
Berneman Z, Lee W, Willekens B, Cras P, Nijs G, De Laere M, Goossens H, Lion E, Martinez Caceres E, Cools N. Towards the Clinical Use of Tolerogenic Dendritic Cells in Multiple Sclerosis by Applying the Immunomodulatory Effects of 1,25-dihydroxyvitamin D3 on Dendritic Cells to Promote Induction of T Cell Hyporesponsiveness to Myelin-Derived Antigens Cytotherapy. 18: S95-S96. DOI: 10.1016/J.Jcyt.2016.03.190 |
0.704 |
|
| 2016 |
Berneman Z, Velde AVd, Anguille S, Willemen Y, Huizing M, Germonpré P, Saevels K, Nijs G, Cools N, Driessche AV, Stein B, Reu HD, Schroyens W, Gadisseur A, Verlinden A, et al. Vaccination with Wilms' Tumor Antigen (WT1) mRNA-Electroporated Dendritic Cells as an Adjuvant Treatment in 60 Cancer Patients: Report of Clinical Effects and Increased Survival in Acute Myeloid Leukemia, Metastatic Breast Cancer, Glioblastoma and Mesothelioma Cytotherapy. 18. DOI: 10.1016/J.Jcyt.2016.03.036 |
0.464 |
|
| 2016 |
Rombouts M, Brussel IV, Mathijssen J, Ammi R, Roth L, Meyer GRYD, Cools N, Fransen E, Winter BYD, Schrijvers DM. Uncovering mouse immune cell dynamics in blood and tissue reservoirs during atherogenesis: implications for therapeutic intervention? Atherosclerosis. 244. DOI: 10.1016/J.Atherosclerosis.2015.10.079 |
0.319 |
|
| 2015 |
Ten Brinke A, Hilkens CM, Cools N, Geissler EK, Hutchinson JA, Lombardi G, Lord P, Sawitzki B, Trzonkowski P, Van Ham SM, Martinez-Caceres EM. Clinical Use of Tolerogenic Dendritic Cells-Harmonization Approach in European Collaborative Effort. Mediators of Inflammation. 2015: 471719. PMID 26819498 DOI: 10.1155/2015/471719 |
0.42 |
|
| 2015 |
Deckx N, Wens I, Nuyts AH, Lee WP, Hens N, Koppen G, Goossens H, Van Damme P, Berneman ZN, Eijnde BO, Cools N. Rapid Exercise-Induced Mobilization of Dendritic Cells Is Potentially Mediated by a Flt3L- and MMP-9-Dependent Process in Multiple Sclerosis. Mediators of Inflammation. 2015: 158956. PMID 26604429 DOI: 10.1155/2015/158956 |
0.365 |
|
| 2015 |
Trzonkowski P, Bacchetta R, Battaglia M, Berglund D, Bohnenkamp HR, ten Brinke A, Bushell A, Cools N, Geissler EK, Gregori S, Marieke van Ham S, Hilkens C, Hutchinson JA, Lombardi G, Madrigal JA, et al. Hurdles in therapy with regulatory T cells. Science Translational Medicine. 7: 304ps18. PMID 26355029 DOI: 10.1126/Scitranslmed.Aaa7721 |
0.399 |
|
| 2015 |
Alpaerts K, Buckinx R, Cools N, Heylen M, Nullens S, Berneman Z, De Winter B, Adriaensen D, Van Nassauw L, Timmermans JP. Effect of schistosomiasis on CX3CR1-expressing mononuclear phagocytes in the ileum and mesenteric lymph nodes of the mouse. Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. 27: 1587-99. PMID 26303459 DOI: 10.1111/Nmo.12658 |
0.378 |
|
| 2015 |
Van Brussel I, Ammi R, Rombouts M, Cools N, Vercauteren SR, De Roover D, Hendriks JM, Lauwers P, Van Schil PE, Schrijvers DM. Fluorescent activated cell sorting: an effective approach to study dendritic cell subsets in human atherosclerotic plaques. Journal of Immunological Methods. 417: 76-85. PMID 25527343 DOI: 10.1016/J.Jim.2014.12.010 |
0.466 |
|
| 2015 |
Van Craenenbroeck AH, Smits EL, Anguille S, Van de Velde A, Stein B, Braeckman T, Van Camp K, Nijs G, Ieven M, Goossens H, Berneman ZN, Van Tendeloo VF, Verpooten GA, Van Damme P, Cools N. Induction of cytomegalovirus-specific T cell responses in healthy volunteers and allogeneic stem cell recipients using vaccination with messenger RNA-transfected dendritic cells. Transplantation. 99: 120-7. PMID 25050468 DOI: 10.1097/Tp.0000000000000272 |
0.401 |
|
| 2015 |
Berneman Z, Velde AVd, Anguille S, Nijs G, Stein B, Cools N, Vermeulen K, Maes M, Willemen Y, Granacher N, Lammens M, Tendeloo VV, Smits E. Declined presentation Dendritic cell vaccination as a post-remission treatment in acute myeloid leukemia Experimental Hematology. 43. DOI: 10.1016/J.Exphem.2015.06.083 |
0.487 |
|
| 2014 |
Zakaria N, Cools N, Berneman Z, Tassignon MJ. Electroporating Human Corneal Epithelial Cells With Interleukin 10 and Fas Ligand pDNA. Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.). 3: 56-63. PMID 26107308 DOI: 10.1097/Apo.0000000000000034 |
0.315 |
|
| 2014 |
Van den Bergh JM, Guerti K, Willemen Y, Lion E, Cools N, Goossens H, Vorsters A, Van Tendeloo VF, Anguille S, Van Damme P, Smits EL. HPV vaccine stimulates cytotoxic activity of killer dendritic cells and natural killer cells against HPV-positive tumour cells. Journal of Cellular and Molecular Medicine. 18: 1372-80. PMID 24979331 DOI: 10.1111/Jcmm.12284 |
0.702 |
|
| 2014 |
Nuyts AH, Ponsaerts P, Van Tendeloo VF, Lee WP, Stein B, Nagels G, D'hooghe MB, Willekens B, Cras P, Wouters K, Goossens H, Berneman ZN, Cools N. Except for C-C chemokine receptor 7 expression, monocyte-derived dendritic cells from patients with multiple sclerosis are functionally comparable to those of healthy controls. Cytotherapy. 16: 1024-30. PMID 24856897 DOI: 10.1016/J.Jcyt.2014.02.016 |
0.413 |
|
| 2014 |
Ogunjimi B, Smits E, Heynderickx S, Van den Bergh J, Bilcke J, Jansens H, Malfait R, Ramet J, Maecker HT, Cools N, Beutels P, Van Damme P. Influence of frequent infectious exposures on general and varicella-zoster virus-specific immune responses in pediatricians. Clinical and Vaccine Immunology : Cvi. 21: 417-26. PMID 24429070 DOI: 10.1128/Cvi.00818-13 |
0.465 |
|
| 2014 |
Van Brussel I, Lee WP, Rombouts M, Nuyts AH, Heylen M, De Winter BY, Cools N, Schrijvers DM. Tolerogenic dendritic cell vaccines to treat autoimmune diseases: can the unattainable dream turn into reality? Autoimmunity Reviews. 13: 138-50. PMID 24120737 DOI: 10.1016/J.Autrev.2013.09.008 |
0.484 |
|
| 2014 |
Thewissen K, Nuyts AH, Deckx N, Van Wijmeersch B, Nagels G, D'hooghe M, Willekens B, Cras P, Eijnde BO, Goossens H, Van Tendeloo VF, Stinissen P, Berneman ZN, Hellings N, Cools N. Circulating dendritic cells of multiple sclerosis patients are proinflammatory and their frequency is correlated with MS-associated genetic risk factors. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 548-57. PMID 24057429 DOI: 10.1177/1352458513505352 |
0.431 |
|
| 2014 |
Bergh JVd, Guerti K, Willemen Y, Lion E, Cools N, Goossens H, Vorsters A, Tendeloo VV, Anguille S, Damme PV, Smits E. Stimulation of cytotoxic activity by killer dendritic cells and natural killer cells against HPV-positive tumor cells by a HPV vaccine F1000research. 5. DOI: 10.7490/F1000Research.1095587.1 |
0.681 |
|
| 2013 |
Deckx N, Lee WP, Berneman ZN, Cools N. Neuroendocrine immunoregulation in multiple sclerosis. Clinical & Developmental Immunology. 2013: 705232. PMID 24382974 DOI: 10.1155/2013/705232 |
0.327 |
|
| 2013 |
Chung CY, Ysebaert D, Berneman ZN, Cools N. Dendritic cells: cellular mediators for immunological tolerance. Clinical & Developmental Immunology. 2013: 972865. PMID 23762100 DOI: 10.1155/2013/972865 |
0.513 |
|
| 2013 |
Nuyts A, Lee W, Bashir-Dar R, Berneman Z, Cools N. Dendritic cells in multiple sclerosis: key players in the immunopathogenesis, key players for new cellular immunotherapies? Multiple Sclerosis Journal. 19: 995-1002. PMID 23369893 DOI: 10.1177/1352458512473189 |
0.455 |
|
| 2013 |
Cools N, Van Camp K, Van Tendeloo V, Berneman Z. mRNA electroporation as a tool for immunomonitoring. Methods in Molecular Biology (Clifton, N.J.). 969: 293-303. PMID 23296941 DOI: 10.1007/978-1-62703-260-5_18 |
0.481 |
|
| 2013 |
Derhovanessian E, Theeten H, Hähnel K, Van Damme P, Cools N, Pawelec G. Cytomegalovirus-associated accumulation of late-differentiated CD4 T-cells correlates with poor humoral response to influenza vaccination. Vaccine. 31: 685-90. PMID 23196209 DOI: 10.1016/J.Vaccine.2012.11.041 |
0.435 |
|
| 2013 |
Berneman ZN, Velde AVd, Anguille S, Willemen Y, Schroyens WA, Gadisseur AP, Vrelust I, Nijs G, Stein B, Cools N, Malfait R, Maes M, Vermeulen K, Tendeloo VFV, Smits EL. Prevention Of Relapse In Acute Myeloid Leukemia By Dendritic Cell Vaccination: Report on a Phase II Study With 29 Patients Blood. 122: 236-236. DOI: 10.1182/Blood.V122.21.236.236 |
0.553 |
|
| 2012 |
Van Brussel I, Berneman ZN, Cools N. Optimizing dendritic cell-based immunotherapy: tackling the complexity of different arms of the immune system. Mediators of Inflammation. 2012: 690643. PMID 22851815 DOI: 10.1155/2012/690643 |
0.502 |
|
| 2012 |
Van Gulck E, Cools N, Atkinson D, Bracke L, Vereecken K, Vekemans M, Van Tendeloo VF, Berneman ZN, Vanham G. Interleukin-12p70 expression by dendritic cells of HIV-1-infected patients fails to stimulate gag-specific immune responses. Clinical & Developmental Immunology. 2012: 184979. PMID 22844321 DOI: 10.1155/2012/184979 |
0.482 |
|
| 2012 |
Zakaria N, Van Grasdorff S, Wouters K, Rozema J, Koppen C, Lion E, Cools N, Berneman Z, Tassignon MJ. Human tears reveal insights into corneal neovascularization. Plos One. 7: e36451. PMID 22590547 DOI: 10.1371/Journal.Pone.0036451 |
0.605 |
|
| 2012 |
Van Gulck E, Vlieghe E, Vekemans M, Van Tendeloo VF, Van De Velde A, Smits E, Anguille S, Cools N, Goossens H, Mertens L, De Haes W, Wong J, Florence E, Vanham G, Berneman ZN. mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients. Aids (London, England). 26: F1-12. PMID 22156965 DOI: 10.1097/Qad.0B013E32834F33E8 |
0.425 |
|
| 2012 |
Berneman ZN, Velde AVd, Anguille S, Cools N, Driessche AV, Nijs G, Stein B, Vrelust I, Gadisseur AP, Schroyens WA, Tendeloo VFV, Smits EL. WT1-targeted dendritic cell vaccination as a postremission treatment to prevent or delay relapse in acute myeloid leukemia. Journal of Clinical Oncology. 30: 2506-2506. DOI: 10.1200/Jco.2012.30.15_Suppl.2506 |
0.551 |
|
| 2011 |
Cools N, Petrizzo A, Smits E, Buonaguro FM, Tornesello ML, Berneman Z, Buonaguro L. Dendritic cells in the pathogenesis and treatment of human diseases: a Janus Bifrons? Immunotherapy. 3: 1203-22. PMID 21995572 DOI: 10.2217/Imt.11.110 |
0.51 |
|
| 2011 |
Van Gulck E, Van Tendeloo VF, Vlieghe E, Vekemans M, Van de Velde A, Smits E, Anguilie S, Cools N, Stein B, Nijs G, Goossens H, Mertens L, De Haes W, Merlin C, Atkinson D, et al. Stimulation of antiviral cellular immune responses by therapeutic vaccination of HIV-1-infected patients with dendritic cells transfected with gag, tat, rev and nef mRNA Retrovirology. 8: P76. DOI: 10.1186/1742-4690-8-S2-P76 |
0.446 |
|
| 2011 |
Berneman ZN, Velde AVd, Anguille S, Cools N, Driessche AV, Tendeloo VFV. 161 Dendritic Cell Vaccination in Acute Myeloid Leukemia Journal of Acquired Immune Deficiency Syndromes. 56: 67. DOI: 10.1097/01.Qai.0000397347.92555.5C |
0.486 |
|
| 2010 |
Van Tendeloo VF, Van de Velde A, Van Driessche A, Cools N, Anguille S, Ladell K, Gostick E, Vermeulen K, Pieters K, Nijs G, Stein B, Smits EL, Schroyens WA, Gadisseur AP, Vrelust I, et al. Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination. Proceedings of the National Academy of Sciences of the United States of America. 107: 13824-9. PMID 20631300 DOI: 10.1073/Pnas.1008051107 |
0.769 |
|
| 2010 |
Camp KV, Cools N, Stein B, Velde AVd, Goossens H, Berneman ZN, Tendeloo VV. Efficient mRNA electroporation of peripheral blood mononuclear cells to detect memory T cell responses for immunomonitoring purposes. Journal of Immunological Methods. 354: 1-10. PMID 20138047 DOI: 10.1016/J.Jim.2010.01.009 |
0.546 |
|
| 2010 |
Smits EL, Cools N, Lion E, Van Camp K, Ponsaerts P, Berneman ZN, Van Tendeloo VF. The Toll-like receptor 7/8 agonist resiquimod greatly increases the immunostimulatory capacity of human acute myeloid leukemia cells. Cancer Immunology, Immunotherapy : Cii. 59: 35-46. PMID 19449004 DOI: 10.1007/S00262-009-0721-8 |
0.697 |
|
| 2010 |
Berneman ZN, Velde Aad, Anguille S, Cools N, Driessche AV, Vermeulen K, Pieters K, Nijs G, Stein B, Smits EL, Schroyens WA, Gadisseur AP, Vrelust I, Vries IJd, Ladell K, et al. WT1-Targeted Dendritic Cell Vaccination as A Post-Remission Treatment to Prevent Full Relapse In Acute Myeloid Leukemia Blood. 116: 16-16. DOI: 10.1182/Blood.V116.21.16.16 |
0.611 |
|
| 2009 |
Anguille S, Smits EL, Cools N, Goossens H, Berneman ZN, Van Tendeloo VF. Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory properties. Journal of Translational Medicine. 7: 109. PMID 20021667 DOI: 10.1186/1479-5876-7-109 |
0.406 |
|
| 2009 |
Smits EL, Anguille S, Cools N, Berneman ZN, Van Tendeloo VF. Dendritic cell-based cancer gene therapy. Human Gene Therapy. 20: 1106-18. PMID 19656053 DOI: 10.1089/Hum.2009.145 |
0.488 |
|
| 2008 |
Cools N, Tendeloo VFIV, Smits ELJM, Lenjou M, Nijs G, Bockstaele DRV, Berneman ZN, Ponsaerts P. Immunosuppression induced by immature dendritic cells is mediated by TGF‐β/IL‐10 double‐positive CD4+ regulatory T cells Journal of Cellular and Molecular Medicine. 12: 690-700. PMID 18419605 DOI: 10.1111/J.1582-4934.2007.00084.X |
0.459 |
|
| 2007 |
Cools N, Ponsaerts P, Van Tendeloo VF, Berneman ZN. Regulatory T cells and human disease. Clinical & Developmental Immunology. 2007: 89195. PMID 18317534 DOI: 10.1155/2007/89195 |
0.456 |
|
| 2007 |
Cools N, Ponsaerts P, Van Tendeloo VF, Berneman ZN. Balancing between immunity and tolerance: an interplay between dendritic cells, regulatory T cells, and effector T cells. Journal of Leukocyte Biology. 82: 1365-74. PMID 17711977 DOI: 10.1189/Jlb.0307166 |
0.514 |
|
| 2007 |
Smits ELJM, Ponsaerts P, Velde ALRVd, Driessche AV, Cools N, Lenjou M, Nijs G, Bockstaele DRV, Berneman ZN, Tendeloo VFIV. Proinflammatory response of human leukemic cells to dsRNA transfection linked to activation of dendritic cells Leukemia. 21: 1691-1699. PMID 17525722 DOI: 10.1038/Sj.Leu.2404763 |
0.42 |
|
| 2006 |
Cools N, Ponsaerts P, Lenjou M, Nijs G, Van Bockstaele DR, Van Tendeloo VF, Berneman ZN. Sensitive detection of human papillomavirus type 16 E7-specific T cells by ELISPOT after multiple in vitro stimulations of CD8+ T cells with peptide-pulsed autologous dendritic cells. Molecular Cancer. 5: 49. PMID 17067378 DOI: 10.1186/1476-4598-5-49 |
0.488 |
|
| 2006 |
Berneman ZN, Smits ELJM, Ponsaerts P, Cools N, Velde ALRVd, Gadisseur AP, Schroyens WA, Tendeloo VFIV. Double-Stranded RNA Acts as a Strong Danger Signal in Human Myeloid Leukemia Cells Leading to Increased Immunogenicity. Blood. 108: 5203-5203. DOI: 10.1182/Blood.V108.11.5203.5203 |
0.462 |
|
| 2006 |
Berneman ZN, Cools N, Tendeloo VFIV, Lenjou M, Nijs G, Bockstaele DRV, Ponsaerts P. Dendritic Cell-Induced T Cell Non-Responsiveness Is Mediated by FOXP3+ and TGF-beta+IL-10+ CD4+ T Cells. Blood. 108: 3891-3891. DOI: 10.1182/Blood.V108.11.3891.3891 |
0.499 |
|
| 2003 |
Cools N, Ponsaerts P, Lenjou M, Nijs G, Baay M, Tjalma WAA, Lardon F, Vermorken JB, Bockstaele DRV, Tendeloo VFIV, Berneman ZN. Efficient Activation And Detection Of Human Papillomavirus Type 16 E7-Specific T Cells Using Autologous Peptide-Pulsed Dendritic Cells International Journal of Gynecological Cancer. 13. DOI: 10.1136/Ijgc-00009577-200303001-00229 |
0.379 |
|
| 2002 |
Ponsaerts P, Van den Bosch G, Cools N, Van Driessche A, Nijs G, Lenjou M, Lardon F, Van Broeckhoven C, Van Bockstaele DR, Berneman ZN, Van Tendeloo VF. Messenger RNA electroporation of human monocytes, followed by rapid in vitro differentiation, leads to highly stimulatory antigen-loaded mature dendritic cells. Journal of Immunology (Baltimore, Md. : 1950). 169: 1669-75. PMID 12165485 DOI: 10.4049/Jimmunol.169.4.1669 |
0.746 |
|
| 2002 |
Ponsaerts P, Tendeloo VFIV, Cools N, Driessche AV, Lardon F, Nijs G, Lenjou M, Mertens G, Broeckhoven CV, Bockstaele DRV, Berneman ZN. mRNA-electroporated mature dendritic cells retain transgene expression, phenotypical properties and stimulatory capacity after cryopreservation. Leukemia. 16: 1324-1330. PMID 12094257 DOI: 10.1038/Sj.Leu.2402511 |
0.502 |
|
| Show low-probability matches. |